Developing defined and scalable 3D culture systems for culturing human pluripotent stem cells at high densities

Cellular and Molecular Bioengineering

Volumn 7, Issue 2, 2014, Pages 172-183

  Lei, Yuguo ^a,b,c   Jeong, Daeun ^a   Xiao, Jifang ^b   Schaffer, David V ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California at Berkeley   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3D culture system; Human embryonic stem cells; Induced pluripotent stem cells; Thermoreversible hydrogel

Indexed keywords

ARTICLE; CELL AGGLOMERATION; CELL AGGREGATION; CELL DENSITY; CELL DIFFERENTIATION; CELL EXPANSION; CELL GROWTH; CELL LINEAGE; CELL LOSS; CELL VIABILITY; CELLULAR PARAMETERS; CULTURE TECHNIQUE; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; HYDROGEL; LIQUID CULTURE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL CULTURE; THERMODYNAMICS;

EID: 84903746950     PISSN: 18655025     EISSN: 18655033     Source Type: Journal    
DOI: 10.1007/s12195-014-0333-z     Document Type: Article

References (42)

1. Amit, M., I. Laevsky, Y. Miropolsky, K. Shariki, M. Peri, and J. Itskovitz-Eldor. Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat. Protoc. 6:572-579, 2011.
2. Badylak, S. F., D. Taylor, and K. Uygun. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu. Rev. Biomed. Eng. 13:27-53, 2011.
3. Chayosumrit, M., B. Tuch, and K. Sidhu. Biomaterials Alginate microcapsule for propagation and directed differentiation of hESCs to definitive endoderm. Biomaterials 31:505-514, 2010.
4. Chen, A. K., et al. Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell Res. 7:97-111, 2011.
5. Chen, G., et al. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 8:424-429, 2011.
6. Chen, V. C., et al. Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res. 8:388-402, 2012.
7. Desbordes, S. C., and L. Studer. Adapting human pluripotent stem cells to high-throughput and high-content screening. Nat. Protoc. 8:111-130, 2012.
8. Fok, E. Y. L., and P. W. Zandstra. Shear-controlled single-step mouse embryonic stem cell expansion and embryoid body-based differentiation. Stem Cells 23:1333-1342, 2005. (Pubitemid 41504921)
9. Gafni, O., et al. Derivation of novel human ground state naive pluripotent stem cells. Nature 504:282-286, 2013.
10. Gerecht, S., J. A. Burdick, L. S. Ferreira, S. A. Townsend, R. Langer, and G. Vunjak-Novakovic. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc. Natl Acad. Sci. U.S.A. 104:11298-11303, 2007. (Pubitemid 47175135)
11. Hsieh, M. H., and H. T. Nguyen. Molecular mechanism of apoptosis induced by mechanical forces. Int. Rev. Cytol. 245:45-90, 2005.
12. James, D., A. J. Levine, D. Besser, and A. Hemmati-Brivanlou. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132:1273-1282, 2005. (Pubitemid 40528787)
13. Kehoe, D. E., D. Jing, L. T. Lock, and E. S. Tzanakakis. Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng. Part A 16, 2010.
14. Kriks, S., et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480:547-551, 2011.
15. Laflamme, M. A., and C. E. Murry. Regenerating the heart. Nat. Biotechnol. 23:845-856, 2005. (Pubitemid 43093128)
16. Lei, Y., S. Gojgini, J. Lam, and T. Segura. The spreading, migration and proliferation of mouse mesenchymal stem cells cultured inside hyaluronic acid hydrogels. Biomaterials 32:39-47, 2011.
17. Lei, Y., and D. V. Schaffer. A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation. Proc. Natl Acad. Sci. U.S.A. 1-10, 2013.
18. Lindvall, O., Z. Kokaia, and A. Martinez-Serrano. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med. 10:S42-S50, 2004. (Pubitemid 38901866)
19. McDevitt, T. C., and S. P. Palecek. Innovation in the culture and derivation of pluripotent human stem cells. Curr. Opin. Biotechnol. 19:527-533, 2008.
20. McNeish, J. Embryonic stem cells in drug discovery. Nat. Rev. Drug Discov. 3:70-80, 2004. (Pubitemid 38088699)
21. Mohamet, L., M. L. Lea, and C. M. Ward. Abrogation of E-cadherin-mediated cellular aggregation allows proliferation of pluripotent mouse embryonic stem cells in shake flask bioreactors. PLoS One 5:e12921, 2010.
22. Nie, Y., V. Bergendahl, D. J. Hei, and J. M. Jones. P.S. scalable culture and cryopreservation of human embryonic stem cells on microcarriers. Biotechnol. Prog. 25:20-31, 2009.
23. Ohgushi, M., and Y. Sasai. Lonely death dance of human pluripotent stem cells: ROCKing between metastable cell states. Trends Cell Biol. 21:274-282, 2011.
24. Ohgushi, M., et al. Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell 7:225-239, 2010.
25. Park, I.-H., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146, 2008.
26. Peerani, R., et al. Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J. 26:4744-4755, 2007. (Pubitemid 350126801)
27. Roger, V. L., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125:e2-e220, 2012.
28. Schulz, T. C., et al. A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS One 7:e37004, 2012.
29. Serra, M., C. Brito, C. Correia, and P. M. Alves. Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol. 30:350-358, 2012.
30. Serra, M., et al. Microencapsulation technology: a powerful tool for integrating expansion and cryopreservation of human embryonic stem cells. PLoS One 6:e23212, 2011.
31. Singh, H., P. Mok, T. Balakrishnan, S. N. B. Rahmat, and R. Zweigerdt. Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res. 4:165-179, 2010.
32. Steiner, D., et al. Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat. Biotechnol. 28:361-364, 2010.
33. Stenberg, J., M. Elovsson, R. Strehl, E. Kilmare, J. Hyllner, and A. Lindahl. Sustained embryoid body formation and culture in a non-laborious three dimensional culture system for human embryonic stem cells. Cytotechnology 63:227-237, 2011.
34. Takahashi, K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872, 2007. (Pubitemid 350138099)
35. Thomson, J. A. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147, 1998. (Pubitemid 28516247)
36. Unger, C., H. Skottman, P. Blomberg, M. S. Dilber, and O. Hovatta. Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum. Mol. Genet. 17:R48-R53, 2008.
37. Vallier, L., M. Alexander, and R. A. Pedersen. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118:4495-509, 2005. (Pubitemid 41556347)
38. Villa-Diaz, L. G., A. M. Ross, J. Lahann, and P. H. Krebsbach. The evolution of human pluripotent stem cell culture: from feeder cells to synthetic coatings. Stem Cells 31:1-7, 2012.
39. Xu, R.-H., et al. NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 3:196-206, 2008.
40. Xu, Y., et al. Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc. Natl. Acad. Sci. U.S.A. 107:8129-8134, 2010.
41. Zang, R., D. Li, I. Tang, J. Wang, and S. Yang. Cell-based assays in high-throughput screening for drug discovery. Int. J. Biotechnol. 1:31-51, 2012.
42. Zweigerdt, R., R. Olmer, H. Singh, A. Haverich, and U. Martin. Scalable expansion of human pluripotent stem cells in suspension culture. Nat. Protoc. 6:689-700, 2011.